Flaxseed enriched diet-mediated reduction in ovarian cancer severity is correlated to the reduction of prostaglandin E2 in laying hen ovaries

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 89, Issue 4, 2013, Pages 179-187

  Eilati, Erfan ^a   Hales, Karen ^a   Zhuge, Yan ^b   Ansenberger Fricano, Kristine ^b   Yu, Rui ^b   van Breemen, Richard B ^b   Hales, Dale Buchanan ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cyclooxygenases; Flaxseed; Laying hen; Ovarian cancer; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E2; PROSTAGLANDIN E3;

ANIMAL TISSUE; ARTICLE; ASCITES; CANCER STAGING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; EGG LAYING; FATTY ACID ANALYSIS; FEMALE; GRANULOSA CELL; HEN; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LAYING HEN; LINSEED; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; OVARY CANCER; OVULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

CYCLOOXYGENASES; FLAXSEED; LAYING HEN; OVARIAN CANCER; PROSTAGLANDIN E(2);

ANIMAL FEED; ANIMALS; AVIAN PROTEINS; CHICKENS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIET; DIETARY SUPPLEMENTS; DINOPROSTONE; FATTY ACIDS, OMEGA-3; FEMALE; FLAX; GENE EXPRESSION; HUMANS; OVARIAN NEOPLASMS; OVARY; OVULATION; POULTRY DISEASES; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE;

EID: 84884531760     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.08.001     Document Type: Article

References (49)

1. Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999, 18:7908-7916.
2. Subbaramaiah K., Dannenberg A.J. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 2003, 24:96-102.
3. Daikoku T., Wang D., Tranguch S., Morrow J.D., Orsulic S., DuBois R.N., Dey S.K. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 2005, 65:3735-3744.
4. Urick M.E., Johnson P.A. Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol. Oncol. 2006, 103:673-678.
5. Hales D.B., Zhuge Y., Lagman J.A., Ansenberger K., Mahon C., Barua A., Luborsky J.L., Bahr J.M. Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus). Endocrine 2008, 33:235-244.
6. E.R. Greene, S. Huang, C.N. Serhan, D. Panigrahy, Regulation of Inflammation in Cancer by Eicosanoids, Prostaglandins & Other Lipid Mediators.
7. Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer 2001, 1:11-21.
8. Terada N., Shimizu Y., Kamba T., Inoue T., Maeno A., Kobayashi T., Nakamura E., Kamoto T., Kanaji T., Maruyama T., Mikami Y., Toda Y., Matsuoka T., Okuno Y., Tsujimoto G., Narumiya S., Ogawa O. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Cancer Res. 2010, 70:1606-1615.
9. Chell S.D., Witherden I.R., Dobson R.R., Moorghen M., Herman A.A., Qualtrough D., Williams A.C., Paraskeva C. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res. 2006, 66:3106-3113.
10. Ma X., Kundu N., Rifat S., Walser T., Fulton A.M. Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis. Cancer Res. 2006, 66:2923-2927.
11. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2007, 57(2007):43-66.
12. Ansenberger K., Richards C., Zhuge Y., Barua A., Bahr J.M., Luborsky J.L., Hales D.B. Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year. Gynecol. Oncol. 2010, 117:341-347.
13. Zhuge Y., Lagman J.A., Ansenberger K., Mahon C.J., Daikoku T., Dey S.K., Bahr J.M., Hales D.B. CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus. Gynecol. Oncol. 2009, 112:171-178.
14. Rodriguez-Burford C., Barnes M.N., Berry W., Partridge E.E., Grizzle W.E. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol. Oncol. 2001, 81:373-379.
15. Barua A., Bitterman P., Abramowicz J.S., Dirks A.L., Bahr J.M., Hales D.B., Bradaric M.J., Edassery S.L., Rotmensch J., Luborsky J.L. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int. J. Gynecol. Cancer 2009, 19:531-539.
16. Johnson P.A., Giles J.R. The hen as a model of ovarian cancer. Nat. Rev. Cancer 2013, 13:432-436.
17. Hardman W.E. Omega-3 fatty acids to augment cancer therapy. J. Nutr. 2002, 132:3508S-3512S.
18. Wu M., Harvey K.A., Ruzmetov N., Welch Z.R., Sech L., Jackson K., Stillwell W., Zaloga G.P., Siddiqui R.A. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int. J. Cancer 2005, 117:340-348.
19. Kobayashi N., Barnard R.J., Henning S.M., Elashoff D., Reddy S.T., Cohen P., Leung P., Hong-Gonzalez J., Freedland S.J., Said J., Gui D., Seeram N.P., Popoviciu L.M., Bagga D., Heber D., Glaspy J.A., Aronson W.J. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin. Cancer Res. 2006, 12:4662-4670.
20. Reddy B.S., Patlolla J.M., Simi B., Wang S.H., Rao C.V. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids. Cancer Res. 2005, 65:8022-8027.
21. Donaldson M.S. Nutrition and cancer: A review of the evidence for an anti-cancer diet. J. Nutr. 2004, 3:19.
22. M.J. Lynch, Medical Laboratory Technology and Clinical Pathology, Saunders (W.B.) Co Ltd; 2nd Revised Edition (1969).
23. J. Bancroft, A. Stevens, Theory and practice of histological techniques, in, Churchill Livingstone, Edinburgh London Melbourne and New York, 1990, pp. P726.
24. Hales D.B. Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 expression. Endocrinology 1992, 131:2165-2172.
25. Hales, Zhuge, Lagman, Ansenberger, Mahon, Barua, Luborsky, Bahr, Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus), Endocrine. 33 (3) (2008) 235-244.
26. Yu R., Zhao G., Christman J.W., Xiao L., Van Breemen R.B. Method development and validation for ultra-high pressure liquid chromatography/tandem mass spectrometry determination of multiple prostanoids in biological samples. J. AOAC Int. 2013, 96:67-76.
27. Yu R., Xiao L., Zhao G., Christman J.W., van Breemen R.B. Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2. J. Pharmacol. Exp. Ther. 2011, 339:716-725.
28. Cao H., Yu R., Tao Y., Nikolic D., van Breemen R.B. Measurement of cyclooxygenase inhibition using liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2011, 54:230-235.
29. Landen C.N., Birrer M.J., Sood A.K. Early events in the pathogenesis of epithelial ovarian cancer. J. Clin. Oncol. 2008, 26:995-1005.
30. Scheideler S.E., Froning G.W. The combined influence of dietary flaxseed variety, level, form, and storage conditions on egg production and composition among vitamin E-supplemented hens. Poult. Sci. 1996, 75:1221-1226.
31. Wong W.Y., Richards J.S. Evidence for two antigenically distinct molecular weight variants of prostaglandin H synthase in the rat ovary. Mol. Endocrinol. 1991, 5:1269-1279.
32. Richards J.S., Russell D.L., Ochsner S., Espey L.L. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol. 2002, 64:69-92.
33. Arico S., Pattingre S., Bauvy C., Gane P., Barbat A., Codogno P., Ogier-Denis E. Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. J. Biol. Chem. 2002, 277:27613-27621.
34. McCarty M.F. Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention. Med. Hypotheses 2012, 78:45-57.
35. Kim I., Kwak H., Lee H.K., Hyun S., Jeong S. beta-Catenin recognizes a specific RNA motif in the cyclooxygenase-2 mRNA 3'-UTR and interacts with HuR in colon cancer cells. Nucleic Acids Res. 2012.
36. Heller D.A., Fan T.M., de Lorimier L.P., Charney S.C., Barger A.M., Tannehill-Gregg S.H., Rosol T.J., Wallig M.A. In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells. J. Vet. Intern. Med. 2007, 21:1048-1055.
37. Lim H., Gupta R.A., Ma W.G., Paria B.C., Moller D.E., Morrow J.D., DuBois R.N., Trzaskos J.M., Dey S.K. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev. 1999, 13:1561-1574.
38. Funahashi H., Satake M., Hasan S., Sawai H., Newman R.A., Reber H.A., Hines O.J., Eibl G. Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth. Pancreas 2008, 36:353-362.
39. Denkins Y., Kempf D., Ferniz M., Nileshwar S., Marchetti D. Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma. J. Lipid Res. 2005, 46:1278-1284.
40. Goodwin J.S., Ceuppens J. Regulation of the immune response by prostaglandins. J. Clin. Immunol. 1983, 3:295-315.
41. K. Brecht, A. Weigert, J. Hu, R. Popp, B. Fisslthaler, T. Korff, I. Fleming, G. Geisslinger, B. Brune, Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2, FASEB J., 25 2408-2417.
42. Munkarah A.R., Morris R., Baumann P., Deppe G., Malone J., Diamond M.P., Saed G.M. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells. J. Soc. Gynecol. Invest. 2002, 9:168-173.
43. Fischer S.M. Prostaglandins and cancer. Front. Biosci. 1997, 2:d482-500.
44. Moonen H.J., Dommels Y.E., van Zwam M., van Herwijnen M.H., Kleinjans J.C., Alink G.M., de Kok T.M. Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells. Mol. Carcinog. 2004, 40:180-188.
45. Smith W.L. Cyclooxygenases, peroxide tone and the allure of fish oil. Curr. Opin Cell Biol. 2005, 17:174-182.
46. Bauknecht T., Siegel A., Meerpohl H.G., Zahradnik H.P. Formation of prostaglandins by ovarian carcinomas. Prostaglandins 1985, 29:665-672.
47. Spinella F., Rosano L., Di Castro V., Natali P.G., Bagnato A. Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion. J. Biol. Chem. 2004, 279:46700-46705.
48. Eilati E., Pan L., Bahr J.M., Hales D.B. Age dependent increase in prostaglandin pathway coincides with onset of ovarian cancer in laying hens. Prostaglandins Leukot Essent Fatty Acids 2012, 87:177-184.
49. Eilati E., Bahr J.M., Hales D.B. Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E in hens. Gynecol. Oncol. 2013, 10.1016/j.ygyno.2013.05.018.